New drug trial aims to ease debilitating endometriosis pain
NCT ID NCT07015268
Summary
This study is testing whether a new drug called KLH-2109 is as effective as a standard medication (leuprorelin acetate) at reducing pelvic pain in people with endometriosis. It involves 288 premenopausal women with confirmed endometriosis. The main goal is to see if the new drug provides similar pain relief over 12 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.